SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-14-009790
Filing Date
2014-06-04
Accepted
2014-06-04 19:57:08
Documents
1
Period of Report
2014-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1636
  Complete submission text file 0001179110-14-009790.txt   3066
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XENOPORT, INC. 3410 CENTRAL EXPRESSWAY SANTA CLARA CA 95051
Business Address
FRIEDMAN CATHY (Reporting) CIK: 0001411874 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30319 | Film No.: 14892275